Key Details of Appointment
Appointee: Mr. Tushar Mehta
Role Appointed To: Head-R&D (API), classified as Senior Management Personnel
Effective Date: 3rd June 2026
Term of Appointment: Full-time employment
Professional Profile of Appointee
Mr. Tushar Mehta possesses over 24 years of experience in API (Active Pharmaceutical Ingredient) Research & Development.
Key Professional Achievements:
- Led more than 100 API development programs.
- Successfully commercialized over 45 APIs from these programs.
- Built and directed an R&D team of 200 scientists.
- Filed multiple USDMFs (US Drug Master Files).
- Steered projects through FDA and EMA regulatory requirements.
Areas of Expertise: Small-molecule APIs, with a focus on complex areas including oncology and antiviral products. Specific experience includes work on Remdesivir and Molnupiravir, along with statins and other advanced APIs.
Previous Employment:
- SVP & Head – R&D (API) at Cadila Pharmaceuticals.
- Associated with Piramal (O2h), Ami Life Sciences, and BDR Life Sciences in R&D leadership roles.
Governance and Compliance Details
Regulatory Reference: This disclosure is made under Regulation 30 of SEBI (LODR) Regulations, 2015, read with Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026.
Director Relationships: The disclosure explicitly states "Not Applicable" regarding relationships between directors.
Financial Impact: The disclosure does not quantify any financial impact of this appointment.
Company and Filing Information
#AlembicPharmaceuticals #ManagementAppointment #SEBIDisclosure #RegulatoryCompliance #PharmaR&D